Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Aug 10, 07:28

Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 10, 03:12

Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Stock Observer

BioNTech SE
Webhose 2026 Aug 09, 07:36

Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 08, 08:57

Citigroup Cuts BioNTech (NASDAQ:BNTX) Price Target to $125.00

BioNTech SE
Webhose 2026 Aug 08, 07:22

Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 08, 05:30

BioNTech (NASDAQ:BNTX) Rating Lowered to Sell at Wall Street Zen

BioNTech SE
Webhose 2026 Aug 05, 01:47

BioNTech SE Q2 Loss Rises

BioNTech SE
Webhose 2026 Aug 04, 22:47

BioNTech deep in the red as demand for vaccines falls

BioNTech SE
Webhose 2026 Aug 04, 19:56

BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar

BioNTech SE
Webhose 2026 Aug 04, 14:04

BioNTech Q2 Earnings Call Highlights

BioNTech SE
Webhose 2026 Aug 04, 12:44

BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market

BioNTech SE
Webhose 2026 Aug 04, 12:08

BioNTech Cuts 2026 Sales Forecast Amid Declining COVID Vaccine Demand, ETPharma

BioNTech SE
Webhose 2026 Aug 04, 11:01

BioNTech lowers 2026 sales outlook as COVID vaccine demand softens

BioNTech SE
Webhose 2026 Aug 03, 11:49

BioNTech taps Sobi executive Oelkers as its next CEO

BioNTech SE
Webhose 2026 Aug 03, 09:29

BioNTech says Sobi's Oelkers will replace Sahin as CEO - AOL

BioNTech SE
Webhose 2026 Jul 30, 12:40

EU greenlights Pfizer and BioNTech's new COVID vaccine

BioNTech SE
Webhose 2026 Jul 29, 21:26

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | Morningstar

BioNTech SE
Webhose 2026 Jul 29, 18:30

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BioNTech SE
Webhose 2026 Jul 28, 12:56

BioNTech (BNTX) Expected to Release Quarterly Earnings on Tuesday

BioNTech SE
Webhose 2026 Jul 28, 00:30

Expanded mRNA Patent Suits Against Pfizer Involving BioNTech's LNP Technology Might Change The Case For Investing In BioNTech (BNTX)

BioNTech SE
Webhose 2026 Jul 27, 08:25

Hsbc Holdings PLC Sells 31,445 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jul 26, 04:39

BioNTech (BNTX) Stock May Look Fully Priced As Pipeline Hopes Build

BioNTech SE
Webhose 2026 Jul 25, 07:58

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Rating of "Moderate Buy" by Brokerages

BioNTech SE
Webhose 2026 Jul 24, 07:23

Aristides Capital LLC Decreases Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jul 23, 00:00

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework

BioNTech SE
Webhose 2026 Jul 21, 10:45

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

BioNTech SE
Webhose 2026 Jul 21, 09:28

SEB Asset Management AB Buys Shares of 200,108 BioNTech SE Sponsored ADR $BNTX - Zolmax

BioNTech SE
Webhose 2026 Jul 21, 09:28

SEB Asset Management AB Buys New Holdings in BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2026 Jul 21, 07:21

BioNTech SE Sponsored ADR $BNTX Shares Sold by Baader Bank Aktiengesellschaft

BioNTech SE
Webhose 2026 Jul 20, 06:29

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2026 Jul 20, 06:18

BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen - Markets Daily

BioNTech SE
Webhose 2026 Jul 19, 06:22

BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?

BioNTech SE
Webhose 2026 Jul 18, 23:36

BioNTech (NASDAQ:BNTX) Rating Increased to Hold at Wall Street Zen - Daily Political

BioNTech SE
Webhose 2026 Jul 18, 05:18

BioNTech (NASDAQ:BNTX) Upgraded to Hold at Wall Street Zen

BioNTech SE
Webhose 2026 Jul 18, 01:23

How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines

BioNTech SE
Webhose 2026 Jul 16, 13:07

Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech - Update | Morningstar

BioNTech SE
Webhose 2026 Jul 16, 00:00

BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center

BioNTech SE
Webhose 2026 Jul 15, 00:00

Pfizer vaccine generates strong immune response in children under 5

BioNTech SE
Webhose 2026 Jul 15, 00:00

Pfizer says vaccine is 100% effective in protecting adolescents

BioNTech SE
Webhose 2026 Jul 11, 13:36

Candriam S.C.A. Lowers Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE

BioNTech News

number1 2025 Dec 05, 00:01

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

number1 2025 Dec 04, 00:00

Fed Independence on the Line? Political Influence in 2026

number1 2025 Dec 04, 00:00

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

number1 2025 Dec 03, 00:00

US Economic Outlook 2026: A Roubini Analysis

number1 2025 Dec 02, 00:01

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Frances Wang 2024 Dec 29, 16:00

Trading wisdom: how can I improve myself as a trader?

Frances Wang 2024 Dec 26, 16:00

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

Frances Wang 2024 Dec 25, 16:00

EQV stock price today: Is EQV Ventures a good investment?

Frances Wang 2024 Dec 25, 16:00

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

Frances Wang 2024 Dec 23, 16:00

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Latest news

Show more
number1 2026 Mar 14, 00:00

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

number1 2026 Mar 14, 00:00

US Economic Signals: Inflation Concerns and Growth Challenges

number1 2026 Mar 14, 00:00

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

number1 2026 Mar 14, 00:00

Apple Slashes App Store Commissions in China for Developers

number1 2026 Mar 14, 00:00

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

number1 2026 Mar 13, 12:07

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

number1 2025 Dec 06, 00:00

India's Silver Demand Surge: New Loan Framework Boosts Market

number1 2025 Dec 04, 00:00

ADP Employment Data and the Fed's Policy Path: A Closer Look

Info

Spread

0.9343

Spread (%)

1.0164 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23530311680

Shares Outstanding

251204366

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-7.76

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Oil price jumps after Biden's comments on possible Israeli strikes on Iran
2024 Oct 05, 09:45

Migration Education Article Test

Trustpilot